High levels of mRNA and protein of the factors of NER ERCC1 and XPD were reported to be associated with resistance to cisplatin therapy in some tumours (e.g. non-small-cell lung cancer) (29, 44). Here, ERCC2 is linked to non-small cell lung carcinoma.